Ranibizumab (biosimilar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ranibizumab (biosimilar), covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab [NA]